Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.3640
+0.0039 (1.08%)
At close: Sep 11, 2026, 4:00 PM EDT
0.3754
+0.0114 (3.13%)
After-hours: Sep 11, 2026, 7:50 PM EDT
Soligenix Employees
As of December 31, 2025, Soligenix had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 2 or -12.50% compared to the previous year.
Employees
14
Change (1Y)
-2
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$731,390
Market Cap
7.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | -2 | -12.50% | 13 | 1 |
| Dec 31, 2024 | 16 | 1 | 6.67% | 14 | 2 |
| Dec 31, 2023 | 15 | 0 | - | 13 | 2 |
| Dec 31, 2022 | 15 | 0 | - | 13 | 2 |
| Dec 31, 2021 | 15 | -3 | -16.67% | 13 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| Imunon | 20 |
| CNS Pharmaceuticals | 8 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
SNGX News
- 5 weeks ago - Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - PRNewsWire
- 5 weeks ago - Soligenix Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Soligenix Earnings release: Q2 2026 - Filings
- 5 weeks ago - Soligenix Proxy statement: Proxy filing - Filings
- 5 weeks ago - Soligenix Proxy statement: Proxy filing - Filings
- 7 weeks ago - Soligenix Proxy statement: Proxy filing - Filings
- 7 weeks ago - Soligenix Proxy statement: Proxy filing - Filings
- 3 months ago - Soligenix to apply for vaccine development funding for Bundibugyo Ebola vaccine - TheFly